Oct 21, 2026 09:26AM
Oct 21, 2026 09:25AM
Oct 6, 2026 09:10AM
Sep 17, 2026 09:11AM
Sep 17, 2026 09:10AM
Sep 9, 2026 04:15PM
Sep 8, 2026 08:02AM Lexaria Bioscience raises $5.9M through warrant exercise
Sep 8, 2026 08:00AM
Sep 4, 2026 09:20AM
Sep 1, 2026 09:15AM
Sep 1, 2026 09:15AM
Aug 24, 2026 09:10AM
Aug 13, 2026 09:02AM
Aug 13, 2026 09:00AM Lexaria Enters a Material Transfer Agreement With PegBio
Jul 30, 2026 11:00AM
Jul 30, 2026 11:00AM
Jul 6, 2026 09:11AM
Jul 6, 2026 09:10AM
Jun 25, 2026 09:10AM
Jun 23, 2026 09:25AM
Jun 17, 2026 09:25AM GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand
Jun 9, 2026 09:25AM
Jun 9, 2026 09:25AM
Jun 3, 2026 09:25AM
May 19, 2026 09:15AM
May 7, 2026 09:25AM
May 5, 2026 09:11AM
May 5, 2026 09:10AM Lexaria Updates Progress on Human Study #7
May 1, 2026 09:25AM
Apr 29, 2026 09:10AM
Apr 29, 2026 09:10AM
Apr 23, 2026 09:05AM
Apr 21, 2026 09:10AM
Apr 15, 2026 09:10AM
Apr 7, 2026 09:10AM Lexaria notes FDA approval of Eli Lilly's oral weight-loss drug Foundayo
Apr 7, 2026 09:10AM
Apr 1, 2026 09:20AM
Apr 1, 2026 09:20AM
Mar 26, 2026 09:20AM
Mar 26, 2026 09:20AM
Mar 24, 2026 09:15AM
Mar 24, 2026 09:15AM Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
Mar 4, 2026 09:25AM
Mar 4, 2026 09:25AM
Feb 5, 2026 09:15AM
Jan 22, 2026 09:22AM
Jan 22, 2026 09:20AM
Jan 12, 2026 09:10AM
Jan 12, 2026 09:10AM Lexaria Releases Annual Letter from the CEO
Dec 30, 2025 09:20AM

335,391 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All